Karin Marie Widstrand

Chief Operating Officer at LU Holding AB

Karin Marie Widstrand

Karin Marie Widstrand

Chief Operating Officer at LU Holding AB

Overview
Career Highlights

LU Holding AB

RelSci Relationships

182

Number of Boards

13

Birthday

1964

Age

55

Contact Data
Trying to get in touch with Karin Marie Widstrand? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Karin Marie Widstrand likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director of Innovation at Lund University

Relationship likelihood: Strong

Head-Department of Biotechnology at Lund University

Relationship likelihood: Strong

Chief Executive Officer at LU Holding AB

Relationship likelihood: Strong

Chairman at Reccan Diagnostics AB

Relationship likelihood: Strong

Head, Department of Arts & Cultural Sciences at Lund University

Relationship likelihood: Strong

Head of Administration at Lund University

Relationship likelihood: Strong

Dean of the Faculty of Medicine at Lund University

Relationship likelihood: Strong

Director at ApoGlyx AB

Relationship likelihood: Strong

Chairman at Gedea Biotech AB

Relationship likelihood: Strong

Co-Founder at EQL Pharma AB

Relationship likelihood: Strong

Paths to Karin Marie Widstrand
Potential Connections via
Relationship Science
You
Karin Marie Widstrand
Chief Operating Officer at LU Holding AB
Education
Class of 1998

The University is ranked as one of the top 100 in the world. They tackle complex problems and global challenges and work to ensure that knowledge and innovations benefit society. They provide education and research in engineering, science, law, social sciences, economics and management, medicine, humanities, theology, fine art, music and drama. Their 47 700 students and 7 500 employees are based at their campuses in Lund, Malm and Helsingborg. The University has a turnover of around SEK 7 475 million (EUR 844 million), of which two thirds is in research and one third in education. They are an international university with global recruitment. They cooperate with 680 partner universities in over 50 countries and are the only Swedish university to be a member of the strong international networks LERU (the League of European Research Universities) and Universitas 21. Two major facilities for materials research are currently under construction in Lund: the MAX IV Laboratory, which will be a world-leading synchrotron radiation laboratory and ESS, a European facility that will be home to the world's most powerful neutron source. These will be of decisive importance for materials and life sciences and for industrial development. In Lund, Medicon Village has also been established and will offer a unique environment for life sciences; integrating research, innovation and enterprise creates the conditions for improved health and quality of life.

Career History
Chief Operating Officer
2009 - Current

LU Holding's investment strategy focuses on innovations and projects needing start-up, early-stage or early expansion capital. Their investment objective has a stringent commercial focus. Their goal is to create value growth for the inventors, Lund University, the investors and society. Their primary geographic focus is Sweden.The firm is an active investment partner which has invested in projects and spin-out firms active in areas such as supervisory and control applications that optimize the production of biogas, mobile communications and intelligent surveillance, Web-based platform for distance learning, computer assisted diagnostic software for nuclear medicine, medical devices for colorectal surgery, algorithms for faster graphics hardware, antibody drug projects within the areas of thrombosis, cancer, atherosclerosis and ophthalmic diseases, peptide therapeutics, analytical separation techniques, and proteomic research for mass spectrometry analysis.

Deputy Director
Current
Business Developer, Head-Sales & Marketing
Prior

MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides.

Boards & Committees
Director
Current

Speximo AB provides emulsifying technology for oil-water based products. The firm’s products and applications include eqmulse and eqlipse. The firm specializes in pickering emulsions and encapsulation technologies. The company was founded by Marilyn Rayner, Timgren Anna Marina Veronica, Petr Dejmek and Malin Elisabet Sjoo in 2012 and is headquartered in Lund, Sweden.

Chairman
Current

Viscosens AB provides viscous fibers for use in bakery products. It offers ready-to-use bread mixes and bread products. The company was founded by Eva Christina Skjöldebrand, Malin Elisabet Sjöö, Lena Åsheim and Elin Marianne Östman in March 2011 and is headquartered in Kavlinge, Sweden.

Director
Current

Reosurf AB is a holding company that develops olive polyphenols and other products from oil-based food sources. It develops patented process for the extraction of polyphenol antioxidants from process used in the production of olive oil. The company was founded by Eva Margareta Tornberg and Charis Galanakis on May 8, 2009 and is headquartered in Lund, Sweden.

Board Member
Current

LU Holding's investment strategy focuses on innovations and projects needing start-up, early-stage or early expansion capital. Their investment objective has a stringent commercial focus. Their goal is to create value growth for the inventors, Lund University, the investors and society. Their primary geographic focus is Sweden.The firm is an active investment partner which has invested in projects and spin-out firms active in areas such as supervisory and control applications that optimize the production of biogas, mobile communications and intelligent surveillance, Web-based platform for distance learning, computer assisted diagnostic software for nuclear medicine, medical devices for colorectal surgery, algorithms for faster graphics hardware, antibody drug projects within the areas of thrombosis, cancer, atherosclerosis and ophthalmic diseases, peptide therapeutics, analytical separation techniques, and proteomic research for mass spectrometry analysis.

Investments
Details Hidden

MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Karin Marie Widstrand. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Karin Marie Widstrand's profile does not indicate a business or promotional relationship of any kind between RelSci and Karin Marie Widstrand.